February 10, 2021

Värde Partners Invests $250 Million in U.S. Residential Real Estate Developments

MINNEAPOLIS and NEW YORK – Värde Partners, a leading global alternative investment firm, today announced it has provided more than $250 million of capital to purchase and fund the development of single family residential projects across three transactions in the U.S.

February 1, 2021

Värde Named Best Client Service – Private Equity (Mid Cap) By The Korea Economic Daily

Värde Partners is honored to be named Best in Client Service in the Private Equity (Mid Cap) asset class by The Korea Economic Daily in 2020.

January 14, 2021

Värde Names New Partner and Senior Managing Directors

MINNEAPOLIS and NEW YORK – Värde Partners, a leading global alternative investment firm, is pleased to announce that Brendan Albee has been promoted to Partner.

January 6, 2021

Värde Partners and J.C. Flowers Complete Sale of Fairstone Financial Holdings Inc. to Duo Bank of Canada

NEW YORK – An investor group led by J.C. Flowers & Co. LLC, a leading private investment firm specializing in the financial services industry, and Värde Partners, Inc., a leading global alternative investment firm, today announced the completion of its previously announced sale of Fairstone Financial Holdings Inc. (“Fairstone” or “the Company”) to Duo Bank of Canada, a Toronto-based financial services provider supported by Stephen Smith, Centerbridge Partners L.P. and Ontario Teachers’ Pension Plan.

December 14, 2020

Värde Partners Co-CEO and CIO, Ilfryn Carstairs, Speaks at Milken Asia Summit

SINGAPORE – Värde Partners, a leading global alternative investment firm, today shares commentary by Co-CEO and CIO Ilfryn Carstairs from the recent Milken Institute Asia Summit.

Värde Partners Funds Bridge Loan for Coral Gables Class A Office Complex

MINNEAPOLIS – Värde Partners, a leading global alternative investment firm, today announced the closing of a refinancing loan for Columbus Center, a 263,000 square foot office and retail complex in Coral Gables, Florida.